Adient director receives 8,208-share equity award

Bushman Julie L reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Bushman Julie L reported acquisition or exercise transactions in this Form 4 filing.

Adient plc director Julie L. Bushman received 8,208 ordinary shares as a stock award for board service under the Adient plc 2021 Omnibus Incentive Plan. The shares were granted at no cash cost to her, reflecting equity-based compensation rather than an open-market purchase.

Following this grant, Bushman directly holds 59,666 Adient ordinary shares. This filing records a routine, compensation-related equity award that increases her direct ownership stake in the company.

Insights

Equity compensation analyst

Routine director stock award increases equity alignment, not a market trade.

Director Julie L. Bushman received 8,208 Adient ordinary shares as compensation under the 2021 Omnibus Incentive Plan. The grant price is shown as $0.0000 per share, indicating a stock award rather than a purchase in the open market.

This type of transaction is common for non-employee directors and is primarily intended to align board incentives with shareholders, not to signal a view on valuation. After the award, she holds 59,666 shares, modestly increasing her direct exposure to Adient’s equity.

Insider Trade Summary

Grant/Award: 8,208 shares

Grant/Award 1 txn

Insider Bushman Julie L

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	8,208	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 59,666 shares (Direct)

Footnotes (1)

1. F1. Shares delivered as compensation for service as a director under the Adient plc 2021 Omnibus Incentive Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Adient (ADNT) director Julie Bushman report?

Julie L. Bushman reported receiving 8,208 Adient ordinary shares as a stock award for service as a director. The shares were granted under the Adient plc 2021 Omnibus Incentive Plan and recorded at a grant price of zero, reflecting equity compensation rather than a cash purchase.

How many Adient (ADNT) shares does Julie Bushman hold after this Form 4?

After the reported grant, Julie L. Bushman directly holds 59,666 Adient ordinary shares. This total includes the 8,208 shares awarded as director compensation, increasing her direct equity stake and aligning her financial interests more closely with other Adient shareholders over time.

Was the Adient (ADNT) Form 4 transaction an open-market buy or a stock award?

The transaction was a stock award, not an open-market buy. The 8,208 ordinary shares were delivered as compensation for Bushman’s service as a director under Adient’s 2021 Omnibus Incentive Plan, with a stated price of zero per share, indicating no cash outlay by her.

What plan governed the Adient (ADNT) share grant to director Julie Bushman?

The share grant to Julie L. Bushman was made under the Adient plc 2021 Omnibus Incentive Plan. This plan authorizes equity-based compensation, and the footnote specifies that the 8,208 shares were delivered as compensation for her service as a director of the company.

Does Julie Bushman’s Adient (ADNT) Form 4 show any share sales or disposals?

The Form 4 shows no sales or disposals by Julie L. Bushman. It reports only an acquisition coded as a grant or award of 8,208 ordinary shares, increasing her direct holdings to 59,666 shares, with no indication of shares being sold or transferred away.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/12/2026 - 04:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bushman Julie L

(Last) (First) (Middle)

49200 HALYARD DRIVE

(Street)

PLYMOUTH MI 48170

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Adient plc [ ADNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	03/10/2026		A		8,208	A	(1)	59,666	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares delivered as compensation for service as a director under the Adient plc 2021 Omnibus Incentive Plan.

Remarks:

	/s/ Brett L. Eilander, attorney-in-fact for Julie L. Bushman	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.